EMD 521873

· Merck KGaA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EMD 521873, covering 2014-06-23 to 2014-07-31. Get the full timeline:

Most recent: Clinical Trial Update: EMD 521873 in Advanced Solid Tumors, MTD Finding [Phase 1]